Status:
UNKNOWN
Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate the associations between vascular parameters and clinical outcomes in patients hospitalized with COVID-19. The vascular function and structure of individuals with COVID-19 ad...
Detailed Description
This is a prospective cohort study conducted at the General Hospital of the University of São Paulo Medical School (HCFMUSP). Male and female participants with SARS-CoV-2 and recently admitted to the ...
Eligibility Criteria
Inclusion
- Patients diagnosed with SARS-CoV-2
- Recently admitted to the hospital (≤ 72 hours)
- Not yet proceeded to ICU care
Exclusion
- Patients transferred from other hospitals
- Participants in delirium state
- Participants with a recent history of endotracheal intubation
Key Trial Info
Start Date :
June 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04714125
Start Date
June 19 2020
End Date
June 1 2022
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP
São Paulo, Brazil, 05403-010